MENU
OPRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

OPRX stock forecast, quote, news & analysis

OptimizeRx Corp is engaged in the healthcare market in the United States... Show more

Interact to see
Advertisement
A.I.Advisor
published price charts
OPRX
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for OPRX with price predictions
Oct 08, 2026

Momentum Indicator for OPRX turns positive, indicating new upward trend

OPRX saw its Momentum Indicator move above the 0 level on September 22, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned positive. In 73 of the 87 cases, the stock moved higher in the following days. The odds of a move higher are at 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for OPRX just turned positive on September 25, 2026. Looking at past instances where OPRX's MACD turned positive, the stock continued to rise in 35 of 44 cases over the following month. The odds of a continued upward trend are 80%.

The 50-day moving average for OPRX moved above the 200-day moving average on October 07, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +2.80% 3-day Advance, the price is estimated to grow further. Considering data from situations where OPRX advanced for three days, in 194 of 262 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

The Aroon Indicator entered an Uptrend today. In 102 of 125 cases where OPRX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 82%.

Bearish Trend Analysis

The 10-day RSI Indicator for OPRX moved out of overbought territory on October 07, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 similar instances where the indicator moved out of overbought territory. In 18 of the 23 cases, the stock moved lower in the following days. This puts the odds of a move lower at 78%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 49 of 60 cases where OPRX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 82%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OPRX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

OPRX broke above its upper Bollinger Band on September 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. OPRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.122) is normal, around the industry mean (7.432). P/E Ratio (31.240) is within average values for comparable stocks, (46.656). Projected Growth (PEG Ratio) (1.608) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (1.463) is also within normal values, averaging (6.065).

The Tickeron SMR rating for this company is 86 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OPRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Teladoc Health (NYSE:TDOC).

Industry description

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

Market Cap

The average market capitalization across the Services to the Health Industry Industry is 2.95B. The market cap for tickers in the group ranges from 708 to 45.33B. VEEV holds the highest valuation in this group at 45.33B. The lowest valued company is OTRKQ at 708.

High and low price notable news

The average weekly price growth across all stocks in the Services to the Health Industry Industry was -0%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 31%. EVH experienced the highest price growth at 17%, while MNDR experienced the biggest fall at -29%.

Volume

The average weekly volume growth across all stocks in the Services to the Health Industry Industry was 14%. For the same stocks of the Industry, the average monthly volume growth was 27% and the average quarterly volume growth was -23%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 74
Price Growth Rating: 51
SMR Rating: 86
Profit Risk Rating: 97
Seasonality Score: 3 (-100 ... +100)
View a ticker or compare two or three
OPRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a provider of unique consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products

Industry ServicestotheHealthIndustry

Industry
Data Processing Services
Address
260 Charles Street
Phone
+1 248 651-6568
Employees
133
Web
https://www.optimizerx.com